These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 17455896)

  • 21. The utility of LNA in microRNA-based cancer diagnostics and therapeutics.
    Stenvang J; Silahtaroglu AN; Lindow M; Elmen J; Kauppinen S
    Semin Cancer Biol; 2008 Apr; 18(2):89-102. PubMed ID: 18295505
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genome-wide identification of human RNA editing sites by parallel DNA capturing and sequencing.
    Li JB; Levanon EY; Yoon JK; Aach J; Xie B; Leproust E; Zhang K; Gao Y; Church GM
    Science; 2009 May; 324(5931):1210-3. PubMed ID: 19478186
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RNA editing in bacteria: occurrence, regulation and significance.
    Bar-Yaacov D; Pilpel Y; Dahan O
    RNA Biol; 2018; 15(7):863-867. PubMed ID: 30071181
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhancing non-coding RNA information content with ADAR editing.
    St Laurent G; Savva YA; Reenan R
    Neurosci Lett; 2009 Dec; 466(2):89-98. PubMed ID: 19751800
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ADAR gene family and A-to-I RNA editing: diverse roles in posttranscriptional gene regulation.
    Valente L; Nishikura K
    Prog Nucleic Acid Res Mol Biol; 2005; 79():299-338. PubMed ID: 16096031
    [No Abstract]   [Full Text] [Related]  

  • 26. MicroRNA-directed regulation: to cleave or not to cleave.
    Mallory AC; Bouché N
    Trends Plant Sci; 2008 Jul; 13(7):359-67. PubMed ID: 18501664
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [RNA interference and molecular pathology of selected diseases].
    Lochmanová J; Bartos M
    Cas Lek Cesk; 2008; 147(12):607-15. PubMed ID: 19235485
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of ADARs in mouse development.
    Walkley CR; Liddicoat B; Hartner JC
    Curr Top Microbiol Immunol; 2012; 353():197-220. PubMed ID: 21725896
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Target site effects in the RNA interference and microRNA pathways.
    Obernosterer G; Tafer H; Martinez J
    Biochem Soc Trans; 2008 Dec; 36(Pt 6):1216-9. PubMed ID: 19021528
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression profiling of microRNAs in cancer cells: technical considerations.
    Sioud M; Cekaite L
    Methods Mol Biol; 2008; 439():179-90. PubMed ID: 18370103
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human microRNAs co-silence in well-separated groups and have different predicted essentialities.
    Boross G; Orosz K; Farkas IJ
    Bioinformatics; 2009 Apr; 25(8):1063-9. PubMed ID: 19131366
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Strategies for profiling microRNA expression.
    Kong W; Zhao JJ; He L; Cheng JQ
    J Cell Physiol; 2009 Jan; 218(1):22-5. PubMed ID: 18767038
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNAs and their emerging roles in immunology.
    Pauley KM; Chan EK
    Ann N Y Acad Sci; 2008 Nov; 1143():226-39. PubMed ID: 19076353
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA Editing Detection and Function: A Combined In Silico and Experimental Approach for the Identification and Validation of Putative Oncogenic Targets.
    Tassinari V; Cesarini V; Silvestris DA; Scafidi A; Cucina L; Gallo A
    Methods Mol Biol; 2021; 2181():253-267. PubMed ID: 32729085
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Purification and assay of ADAR activity.
    Keegan LP; Rosenthal JJ; Roberson LM; O'Connell MA
    Methods Enzymol; 2007; 424():301-17. PubMed ID: 17662847
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of microRNA with antisense oligonucleotides.
    Esau CC
    Methods; 2008 Jan; 44(1):55-60. PubMed ID: 18158133
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prediction of microRNA targets.
    Mazière P; Enright AJ
    Drug Discov Today; 2007 Jun; 12(11-12):452-8. PubMed ID: 17532529
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Probing adenosine-to-inosine editing reactions using RNA-containing nucleoside analogs.
    Maydanovych O; Easterwood LM; Cui T; Véliz EA; Pokharel S; Beal PA
    Methods Enzymol; 2007; 424():369-86. PubMed ID: 17662850
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative genomic and bioinformatic approaches for the identification of new adenosine-to-inosine substrates.
    Sixsmith J; Reenan RA
    Methods Enzymol; 2007; 424():245-64. PubMed ID: 17662844
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A role for microRNAs in the development of the immune system and in the pathogenesis of cancer.
    Kanellopoulou C; Monticelli S
    Semin Cancer Biol; 2008 Apr; 18(2):79-88. PubMed ID: 18291671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.